Item 1A. Risk Factors   Information regarding risk factors is discussed in Item 1A, “Risk Factors” of the Company’s Form 10-K for the year ended December 31, 2007. There have been no material changes from the risk factors previously disclosed in the Company’s Form 10-K.     38     Table of Contents   PART II. OTHER INFORMATION   Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   The following table sets forth the Company’s repurchases of equity securities registered under Section 12 of the Exchange Act that occurred in the three months ended September 30, 2008.      Period       Total number of shares (or units) purchased (a)       Average price paid per share (or unit)       Total number of shares (or units) purchased as part of publicly announced plans or programs       Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs (b)                                                   July 2008 (July 1 – July 31)       1,382       $   60.76       –       8,385,400                                                       August 2008 (August 1 – August 31)       1,557       $   49.56       –       8,385,400                                                       September 2008 (September 1 – September 30)       1,845       $   42.19       –       8,385,400                                                   Total       4,784               –                  (a) Includes 163 shares delivered in exchange for the exercise of stock options and restricted share awards to cover award cost and tax withholding and 4,621 shares for company-funded purchases made by the Company’s 401(k) plans.   (b) Equitable’s Board of Directors previously authorized a share repurchase program with a maximum of 50.0 million shares and no expiration date. The program was initially publicly announced on October 7, 1998 with subsequent amendments announced on November 12, 1999, July 20, 2000, April 15, 2004 and July 13, 2005.     39     Table of Contents   PART II. OTHER INFORMATION      Item 6.   Exhibits